Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia

Alzheimer's and Dementia

Volumn 11, Issue 8, 2015, Pages 994-1004

  Sabbagh, Marwan N ^a,b,c   Chen, Kewei ^b,d,e   Rogers, Joseph ^f   Fleisher, Adam S ^b,d   Liebsack, Carolyn ^a,b   Bandy, Dan ^b,d   Belden, Christine ^a,b   Protas, Hillary ^b,d   Thiyyagura, Pradeep ^b,d   Liu, Xiaofen ^b,d   Roontiva, Auttawut ^b,d   Luo, Ji ^b,d   Jacobson, Sandra ^a,b   Malek Ahmadi, Michael ^a,b   Powell, Jessica ^a,b   Reiman, Eric M ^b,c,d,g  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b ARIZONA ALZHEIMER S CONSORTIUM   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d BANNER ALZHEIMER S INSTITUTE   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f SRI INTERNATIONAL   (United States)

^g TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Dementia; Down syndrome; FDG PET; Florbetapir; Imaging; PET

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18; FLUORODEOXYGLUCOSE F 18; ANILINE DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR;

ADULT; AGE; ALZHEIMER DISEASE; ANTHROPOMETRIC PARAMETERS; ARTICLE; CEREBRAL METABOLIC RATE FOR GLUCOSE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GRAY MATTER VOLUME; HIPPOCAMPAL VOLUME; HUMAN; MALE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHIATRIC EMERGENCY SERVICE;

ADULT; ALZHEIMER DISEASE; ANILINE COMPOUNDS; BRAIN; DOWN SYNDROME; EMERGENCY SERVICES, PSYCHIATRIC; ETHYLENE GLYCOLS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84939251964     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.01.006     Document Type: Article

References (44)

1. M.A. Davidson Primary care for children and adolescents with Down syndrome Pediatr Clin North Am 55 2008 1099 1111
2. D.M. Mann, and M.M. Esiri The pattern of acquisition of plaques and tangles in the brains of participants under 50 years of age with Down's syndrome J Neurol Sci 89 1989 169 179
3. K.E. Wisniewski, A.J. Dalton, C. McLachlan, G.Y. Wen, and H.M. Wisniewski Alzheimer's disease in Down's syndrome: clinicopathologic studies Neurology 35 1985 957 961
4. W.B. Zigman, and I.T. Lott Alzheimer's disease in Down syndrome: neurobiology and risk Ment Retard Dev Disabil Res Rev 13 2007 237 246
5. A.H. Bittles, C. Bower, R. Hussain, and E.J. Glasson The four ages of Down syndrome Eur J Public Health 17 2007 221 225
6. J. Landt, J.C. D'Abrera, A.J. Holland, F.I. Aigbirhio, T.D. Fryer, R. Canales, and et al. Using positron emission tomography and carbon 11-labeled Pittsburgh compound B to image brain fibrillar beta-amyloid in adults with Down syndrome: safety, acceptability, and feasibility Arch Neurol 68 2011 890 896
7. M.N. Sabbagh, A. Fleisher, K. Chen, J. Rogers, C. Berk, E. Reiman, and et al. Positron emission tomography and neuropathologic estimates of fibrillar amyloid-beta in a patient with Down syndrome and Alzheimer's disease Arch Neurol 68 2011 1461 1466
8. L.D. Nelson, P. Siddarth, V. Kepe, K.E. Scheibel, S.C. Huang, J.R. Barrio, and et al. Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome Arch Neurol 68 2011 768 774
9. B.L. Handen, A.D. Cohen, U. Channamalappa, P. Bulova, S.A. Cannon, W.I. Cohen, and et al. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B Alzheimers Dement 8 2012 496 501
10. P. Pietrini, A. Dani, M.L. Furey, G.E. Alexander, U. Freo, C.L. Grady, and et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia Am J Psychiatry 154 1997 1063 1069
11. R.J. Haier, K. Head, E. Head, and I.T. Lott Neuroimaging of individuals with Down's syndrome at-risk for dementia: evidence for possible compensatory events Neuroimage 39 2008 1324 1332
12. E. Head, I.T. Lott, D. Patterson, E. Doran, and R.J. Haier Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention J Alzheimers Dis 11 2007 61 76
13. A. Dani, P. Pietrini, M.L. Furey, A.R. McIntosh, C.L. Grady, B. Horwitz, and et al. Brain cognition and metabolism in Down syndrome adults in association with development of dementia Neuroreport 7 1996 2933 2936
14. S.J. Teipel, M.B. Schapiro, G.E. Alexander, J.S. Krasuski, B. Horwitz, C. Hoehne, and et al. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome Am J Psychiatry 160 2003 1870 1878
15. S.J. Teipel, G.E. Alexander, M.B. Schapiro, H.J. Möller, S.I. Rapoport, and H. Hampel Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry Brain 127 Pt 4 2004 811 824
16. J.S. Krasuski, G.E. Alexander, B. Horwitz, S.I. Rapoport, and M.B. Schapiro Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease Am J Psychiatry 159 2002 74 81
17. N.S. White, M.T. Alkire, and R.J. Haier A voxel-based morphometric study of nondemented adults with Down syndrome Neuroimage 20 2003 393 403
18. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, and et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
19. H.M. Evenhuis, M.M.F. Kengen, and H.A.L. Eurlings Screening instrument for diagnosis of dementia in people with learning disabilities (2007) 2007 UK adaptation, Pearson Assessment London
20. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-Mental State J Psychiatr Res 12 1975 189 198
21. A. Dalton, and B. Fedor Dyspraxia scale for adults with Down syndrome 1997 NYS Institute for Basic Research in Developmental Disabilities New York, NY
22. J. Saxton, K.L. McGonigle, A.A. Swihart, and F. Boller The severe impairment battery 1993 Harcourt Assessment London, UK
23. S.S. Sparrow, D.V. Cicchetti, and D.A. Balla Vineland-II: Vineland Adaptive Behavior Scales 2nd ed. 2007 Pearson Oxford
24. A.S. Fleisher, K. Chen, Y.T. Quiroz, L.J. Jakimovich, M.G. Gomez, C.M. Langois, and et al. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study Lancet Neurol 11 2012 1057 1065
25. R.J. Caselli Reiman EM Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention J Alzheimers Dis 33 Suppl 1 2013 S405 S416
26. H.D. Protas, K. Chen, J.B. Langbaum, A.S. Fleisher, G.E. Alexander, W. Lee, and et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease JAMA Neurol 70 2013 320 325
27. B. Fischl, D.H. Salat, E. Busa, M. Albert, M. Dieterich, C. Haselgrove, and et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain Neuron 33 2002 341 355
28. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, D. Harvey, and et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
29. J.G. Sled, A.P. Zijdenbos, and A.C. Evans A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Trans Med Imaging 17 1998 87 97
30. J. Ashburner, and K.J. Friston Voxel-based morphometry - the methods Neuroimage 11 6 Pt 1 2000 805 821
31. J. Ashburner A fast diffeomorphic image registration algorithm Neuroimage 38 2007 95 113
32. J. Ashburner Computational anatomy with the SPM software Magn Reson Imaging 27 2009 1163 1174
33. R.D. Lane, K. McRae, E.M. Reiman, K. Chen, G.L. Ahern, and J.F. Thayer  Neural correlates of heart rate variability during emotion Neuroimage 44 2009 214 223
34. K.M. Rodrigue, K.M. Kennedy, M.D. Devous, J.R. Rieck, A.C. Hebrank, R. Diaz-Arrastia, and et al. β-Amyloid burden in healthy aging: regional distribution and cognitive consequences Neurology 78 2012 387 395
35. G.E. Alexander, K. Chen, P. Pietrini, S.I. Rapoport, and E.M. Reiman Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies Am J Psychiatry 159 2002 738 745
36. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, and et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc Natl Acad Sci U S A 101 2004 284 289
37. A.M. Fjell, K.B. Walhovd, C. Fennema-Notestine, L.K. McEvoy, D.J. Hagler, D. Holland, and et al. One-year brain atrophy evident in healthy aging J Neurosci 29 2009 15223 15231
38. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, S.K. Ziolko, and et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J Neurosci 27 2007 6174 6184
39. C.A. Lemere, J.K. Blusztajn, H. Yamaguchi, T. Wisniewski, T.C. Saido, and D.J. Selkoe Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation Neurobiol Dis 3 1996 16 32
40. N.P. Azari, K.D. Pettigrew, P. Pietrini, B. Horwitz, and M.B. Schapiro Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome Dementia 5 1994 69 78
41. P.S. Kishnani, B.R. Sommer, B.L. Handen, B. Seltzer, G.T. Capone, G.A. Spiridigliozzi, and et al. The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome Am J Med Genet A 149A 2009 1641 1654
42. P.S. Kishnani, J.H. Heller, G.A. Spiridigliozzi, I. Lott, L. Escobar, S. Richardson, and et al. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17 Am J Med Genet A 152A 2010 3028 3035
43. I.T. Lott, E. Doran, V.Q. Nguyen, A. Tournay, E. Head, and D.L. Gillen Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation Am J Med Genet A 155A 2011 1939 1948
44. T. Kondoh, A. Kanno, H. Itoh, M. Nakashima, R. Honda, M. Kojima, and et al. Donepezil significantly improves abilities in daily lives of female Down syndrome participants with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial Int J Psychiatry Med 41 2011 71 89